Clinical trial
VSL#3 Versus Placebo in Maintenance of Remission in Crohn's Disease
NCT00114465 · Orphan Australia, Other · Completed
Key facts
| NCT number | NCT00114465 |
|---|---|
| Title | VSL#3 Versus Placebo in Maintenance of Remission in Crohn's Disease |
| Official title | Randomized, Double-Blind, Placebo-Controlled Study of VSL#3 Versus Placebo in the Maintenance of Remission in Crohn's Disease |
| Lead sponsor | Orphan Australia, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Drug, Other |
| Interventions | VSL#3, Placebo |
| Enrollment | 38 |
| Start date | Jun 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jun 15, 2005 |
| Last update posted | Sep 18, 2009 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: